logo
Neurologist solves New York woman's mystery illness 6 years after her symptoms started

Neurologist solves New York woman's mystery illness 6 years after her symptoms started

CBS News2 days ago
After many years and multiple doctors visits, a New York woman finally has answers to a medical mystery that drastically altered her life.
Maureen Henry, of Rockland County, said she experienced uncontrollable cognitive problems, extreme fatigue, and involuntary face and body tics, but none of her doctors were able to pinpoint the problem until now.
"Living with a mystery illness, it's very isolating," said Henry, who went six years without any answers to what was causing her symptoms.
Uncontrollable symptoms forced Henry to quit her job at a hospital as a newborn photographer, the 58-year-old mother of four told CBS News New York.
"They were constant, relentless," she said. "It was really hard. Once I stopped working, things got worse."
The symptoms started at a very stressful time in her life, Henry said. They came on after she lost her parents to different illnesses on the same day.
"Something in my brain just switched off," she said.
Henry's medical mystery was finally solved by Dr. Christian Amlang, a neurologist and movement disorder specialist with Maimonides Health, she said.
Amlang diagnosed Henry with functional neurological disorder, or FND, after she said she saw seven other doctors and took many medications over the years.
"It is a condition that affects the brain communication. So there's a breakdown of certain, we call it, networks in the brain, and the result is that there is a disconnect between different parts of the brain, and the brain and the body," Amlang said. "We're not quite sure [what causes FND]. We do think that there are a lot of predisposing factors ... you know, trauma and psychological triggers."
FND treatment does not include medication, the doctor said. It takes a multidisciplinary approach, including psychotherapy and neurological physical therapy, he said.
"The point is not to necessarily be right or be good at these [exercises]. It's to be super engaged, mind and body," Henry said. "It's not a quick fix. It takes a lot of work."
Henry said it took roughly four months of physical therapy before she started feeling more like herself.
Now, Henry says she's "feeling amazing" and hoping to empower others when it comes to their health.
"Be persistent. Keep advocating for yourself," she said.
In fact, since finding the right doctor, she says she traveled, got trained in scuba diving and started living life to the fullest.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025
Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025

Yahoo

time4 minutes ago

  • Yahoo

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025

RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as hypertensive nephropathy, obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the second quarter ended June 30, 2025, after the financial markets close on Tuesday, August 12, 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13754684 Webcast: Webcast Link A live webcast of the conference call may also be found on the 'News & Events' page in the Investor Relations section of the Mineralys Therapeutics website. About Mineralys TherapeuticsMineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as hypertensive nephropathy, OSA and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit Follow Mineralys on LinkedIn, Twitter and Bluesky. Contact: Investor Relations investorrelations@ Media RelationsMelyssa WeibleElixir Health Public RelationsPhone:1-201-723-5805Email: mweible@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store